ABSTRACT We have produced and characterized monoclonal antibodies that label antigenic determinants distributed among three distinct, nonoverlapping peptide domains of the 200-kD heavy chain of avian smooth muscle myosin. Mice were immunized with a partially phosphorylated chymotryptic digest of adult turkey gizzard myosin. Hybridoma antibody specificities were determined by solid-phase indirect radioimmunoassay and immunoreplica techniques. Electron microscopy of rotary-shadowed samples was used to directly visualize the topography of individual [antibody. antigen] complexes.
The structural organization of myosin molecules is conserved throughout evolution and among myosins of disparate tissue origin. A pair of heavy chains comprises both carboxy-terminal a-helical domains that form a coiled-coil "tail" and amino-terminal domains that form two globular "heads." Each head is associated with a regulatory and an essential light chain. Interaction of myosin heads with filamentous actin, activation by actin of the Mg2+-ATPase of the myosin molecule, and functional coupling between ATP hydrolysis and force generation are essential and ubiquitous processes for contraction and other motile events in muscle and nonmuscle cells (1) . In vertebrate striated muscles, myosin polymorphism is apparent not only for light chains characteristic of specific muscle classes, fiber types, and developmental stages (2) (3) (4) , but also for myosin heavy chains of skeletal (5) (6) (7) (8) (9) and cardiac (10-12) muscle myosin. In contrast, the structural and functional organization and development of myosin in vertebrate smooth muscle have received relatively little study. We have produced a series of monoclonal antibodies (mAb) ~ directed against antigenic determinants (epitopes) of smooth muscle myosin, as probes for such investigations.
We report here results obtained with hybridoma antibodies that recognize three distinct nonoverlapping domains of the heavy chain of avian smooth muscle myosin: heavy meromyosin (HMM) subfragment-I (S-l), subfragment-2 (S-2), ~Abbreviations used in this paper. HMM, heavy meromyosin; ~251-F(ab')2, ~251-1abeled F(ab')2 fragment of affinity-purified sheep lgG directed against mouse immunoglobulins; LCIT, 17-kD myosin light chain; LC20, 20-kD myosin light chain; LMM, light meromyosin; mAb, monoclonal antibody; 32P-LC2o, LC2o radiophosphorylated by myosin light chain kinase; S-l, HMM subfragment-1; S-2, HMM subfragment-2. and light meromyosin (LMM). We have studied functional aspects of smooth muscle myosin by assaying for antibodydependent effects on the actin-activated HMM Mg2*-ATPase and for actin-dependent effects on mAb binding. We have investigated the structure of the smooth muscle myosin heavy chain, not only with its purified peptide domains, immunoblot techniques, and electron microscopy of rotary-shadowed [antibody.antigen] complexes, but also in conjunction with radiophosphorylated myosin light chains (13) as a unique structural probe. 
MATERIALS AND METHODS

Materials
Production of Monoclonal Antibodies:
To prepare smooth muscle myosin as immunogen and as antigen for initial screening assays, myosin was purified from adult turkey gizzards (14) . Gizzard myosin was phosphorylated by myosin light chain kinase (14) to ~0.5 mol PO4/mol 20-kD myosin light chain (LC2o) and subsequently subjected to limited proteolysis with chymotrypsin (1 mg/100 mg myosin) at 25"C in 500 mM NaCI, 10 mM MgC12, 50 mM Tris-HCI, pH 7.4. The reaction was stopped after 10 rain with the addition of phenylmethylsulfonyl fluoride to 0.5 mM. Female 6-wk-old BALB/c mice were inoculated intraperitoneally at 0 and 8 d with 75 #g of myosin chymotryptic digest in complete Freund's adjuvant, and at 15 d with 75 ug of myosin digest intraveneously without adjuvant. Cell fusion at 18 d and subsequent derivation of hybridoma cell lines (15) were as previously described ( 16, 17) .
Solid-Phase Indirect Radioimmunoassay:
Myosin chymotryptic digest (10 #g in 2 #l per well of 0.5 M NaCl, 50 mM HEPES, pH 7.5) was immunobilized by evaporation onto 96-well nitrocellulose filtration plates, reacted sequentially with 50 #l/well of hybridoma-conditioned medium and with 4 nM ~251-F(ab')2. Bound radioactivity was determined by gamma-spectrometry. Hybridoma-conditioned media and t2~I-F(ab')2 solutions were centrifuged immediately before use (11,600 g for 60 min and 178,000 g for l0 min, respectively), which substantially reduced background variance attributed to nonspecifically bound IgG. All results shown [fmol ~251-F(ab')2 specifically bound per well] are corrected both for hybridoma antibody bound to immobilized bovine serum albumin (BSA) and for nonspecifically bound P3-X63.Ag8 IgG [typically I-1.5% of total 1251-F(ab')2]. Replicates varied by <5%.
Preparation of Tissue Homogenates:
Embryonated White Leghorn chick eggs were obtained from Truslow Farms (Chestertown, MD). Portions of 19-d embryonic chick organs were homogenized at 4"C in 5 vol of 40 mM NaCL l0 mM HEPES. pH 7.5, I mM MgCI2, 5 mM EDTA, 1 mM NAN3, l mM dithiothreitol, l mM phenylmethylsulfonyl fluoride, l0 #M leupeptin, with 12 strokes of a motor-driven Potter-EIvehjem homogenizer at the highest setting (Model 5VB-C, Eastern Mixers, Inc., Clinton, CT), adjusted to 0.5 M NaCl, and protein concentration determined (18) .
Preparation of Proteins:
HMM and LMM were produced from phosphorylated myosin by limited proteolysis with chymotrypsin (l mg/100 mg myosin) in the presence of ATP and terminated by the addition of 0.5 mM phenylmethylsulfonyl fluoride. HMM then was purified as described by Sellers et al. (19) . whereas LMM was purified essentially as described by Margossian and Lowey (20) . S-I and rod were produced by limited digestion of myosin with papain (0.01 U/rag myosin) and were then purified as described by Greene et al. (21) and Margossian and Lowey (20) , respectively. S-2 was produced by chymotryptic digestion of myosin rod and purified by the method of Margossian and Lowey (20) with the inclusion of low ionic strength, 10 mM MgCI2 precipitation of contaminating LMM by centfifugation at 40,000 g for 20 min. LCzo and the 17-kD (LC~7) light chains of gizzard myosin were isolated (13) , and LC2o was radiophosphorylated as described (14) . Actin was purified from rabbit skeletal muscle by the method of Spudich and Watt (22) as modified by Eisenberg and Kielley (23) . Protein concentrations of myosin subfragments were calculated from absorbance measurements at 280 nm using extinction coefficients reported by Margossian and Lowey (20) . Monoclonal lgG was purified by precipitation in 70% (NH4)2SO4 followed by ion-exchange chromatography on DEAE-cellulose as described by Parham (24) and was homogeneous by SDS PAGE.
Western Blots: Peptides were resolved by SDS PAGE, performed as described by Laemmli (25) or as modified by Matsudaira and Burgess (26) . Electrophoretic transfer of peptides to nitrocellulose was performed according to Towbin et al. (27) at l0 V for 16 h at 4"C in 25 mM Tris-HCl, 192 mM glycine. 20% methanol (pH 7.5). Polypeptides of tissue homogenates were transferred in the presence of 0.1% SDS to ensure transfer of the 200-kD myosin heavy chain. Each nitrocellulose replica was reacted sequentially for 2 h at 4"C with hybridoma-conditioned medium or purified monoclonal IgG (5 pg/ml) and with 0.2 nM ~2~l-F(ab')2. The distribution of specifically bound monoclonal lgG was determined by autoradiography at -70"C employing Kodak X-Omat AR film and X-Omatic fine intensifying screens. No binding of ~2Sl-F(ab')2 to peptides of purified myosin fragments or of tissue homogenates was detected in the presence of equivalent concentrations of parental P3-X63.Ag8 myeloma lgG or normal mouse lgG.
Low-angle Platinum Shadowing of [mAb. HMM] Complexes:
Adult turkey gizzard myosin or HMM at 120 pg/ml in 0.5 M ammonium acetate was incubated with 150 pg/ml of DE52-purified monoclonal IgG for 16 h at 4"C, and diluted to 60 ug/ml of antigen in 50% glycerol immediately before spraying onto freshly cleaved mica. Low-angle rotary shadowing with platinum and subsequent carbon-coating of metal replicas was performed in a Balzers vacuum evaporator (Balzers, Hudson, NH) by the method of Tyler and Branton (28) . A Zeiss EM-10 electron microscope (Carl Zeiss, Inc.. Thornwood, NY) was employed at 60-kV accelerating voltage.
RESULTS
Specificity for Avian Smooth Muscle Myosin: Purified Myosins
63 of 173 hybridoma colonies assayed 14-24 d after cell fusion produced detectable antibody directed against a chymotryptic digest of partially phosphorylated adult turkey gizzard myosin. We report results obtained with three hybridoma cell lines, each recloned three times at limiting dilution to ensure homogeneity and adapted to growth in roller bottles yielding ~ 150 mg/liter of monoclonal immunoglobulin. The binding specificity of each mAb was first determined in the presence of 10-9-10 -5 g/well of myosin purified from adult turkey gizzard, chicken pectoralis, or calf aorta (Fig. 1 ). Antibodies TGM-I and TGM-3, under the conditions shown, recognized intact turkey gizzard myosin but neither avian skeletal muscle myosin nor mammalian smooth muscle myosin. Antibody was comparably bound to myosin purified from gizzards of adult turkey versus adult chicken (data not shown), mAb TGM-2, which recognized an epitope of digested gizzard myosin in the screening assay, did not, however, 
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Tissue HO~A ogenates bind to intact myosin. None of the antibodies tested bound to rabbit skeletal muscle HMM or to nonmuscle myosin purified from chicken intestinal brush border.
Tissue Homogenates
To determine the tissue specificity of epitopes recognized by antibodies TGM-1 and TGM-3, SDS-denatured homogenares of 19-d chicken embryo tissues were analyzed by indirect radioimmunoassay (Fig. 2) . Antibody TGM-3 bound to homogenates of 19-d embryonic chicken gizzard, aorta, and intestine, but not to cardiac ventricle, pectoralis, or cerebellum. The binding of mAb TGM-3 was specific for the 200-kD smooth muscle myosin heavy chain as demonstrated in the accompanying Western blot (Fig. 3) . In contrast, using antibody TMG-1, little binding to myosin in homogenates of 19-d embryonic chicken smooth muscle was detected by indirect radioimmunassay (Fig. 2) . Results demonstrating binding of each antibody in the presence of purified adult turkey gizzard myosin are included for comparison. Thus, antibody TGM-1 may identify a region of smooth muscle myosin that undergoes developmental regulation and is preferentially expressed in the adult. None of the antibodies bound SDS-denatured homogenates of uterus, stomach, cardiac ventricle, pectoralis, cerebellum, or spleen of adult rat (data not shown), indicating specificity for avian smooth muscle myosin.
Subfragments of Smooth Muscle Myosin Heavy Chain
Binding of each antibody was determined in the presence of purified intact adult turkey gizzard myosin or its purified subunits by indirect radioimmunoassay (Fig. 4) and by Western blot (Fig. 5) . mAb TGM-I identified intact myosin, HMM, and S-l, but not S-2, rod, or LMM. mAb TGM-3 recognized intact myosin, rod, and LMM, but not HMM, S-1, or S-2. Thus, the TGM-1 epitope was localized to S-l, and the TGM-3 epitope to LMM. mAb TGM-2, which did not bind to intact myosin, bound to HMM and S-2 but not S-1, indicating that a free carboxyterminus of S-2 must be present for recognition. To confirm this localization of the TGM-2 binding site, HMM was digested with papain, and myosin rod was digested with chymotrypsin (Fig. 6, A and E) . The resultant peptides were analyzed by Western blot. mAb TGM-2 bound to undigested HMM, to a number of intermediate fragments, and to S-2 produced in a time-dependent manner from the carboxyterminus of HMM (Fig. 6 C) . Whereas no binding to undigested rod or its intermediate fragments was detected, mAb TGM-2 did bind to S-2 cleaved from the amino-terminus of 
rod (Fig. 6G). Thus, [125I-F(ab'h.TGM-2.S-2] complexes
were not formed when the S-2:LMM junction was intact, and we postulate that the TGM-2 binding site is at or near the S-2:LMM junction, mAb TMG-I (Fig. 6 , B and F) and TGM-3 (Fig. 6 , D and H) identified distinct families of proteolytic peptides derived only from HMM or from rod, respectively, and are shown for comparison. The globular S-1 head produced after digestion of myosin with papain retains the actin-binding and actin-activated Mg2÷-ATPase activity of the intact myosin molecule (29) . Controlled proteolysis of skeletal myosin S-1 with trypsin (30-32) results in formation of an amino-terminal 25-kD adenine nucleotide-binding fragment, a 50-kD central fragment containing one of two actin cross-linking sites, and a carboxy-terminal 20-kD fragment that contains the second actin cross-linking site, the S-1:S-2 junction, and a site of probable association with myosin light chains (13, 33, 34) . Smooth muscle myosin S-I similarly digested with trypsin results in homologous fragments of apparent molecular weight 29-, 50-, and 26-kD (references 13 and 35; Fig. 7A ). The Western blot employing mAb TGM-I localizes the TGM-1 epitope (Fig. 7 C) to the 50-kD tryptic fragment; the antibody bound neither to the amino-terminal 29-kD fragment, nor to the carboxy-terminal 26-kD fragment that binds radiophosphorylated 20-kD light chains of gizzard myosin (see reference 13 and Fig. 7 B) . The 28-kD band detected in the immunoblot only at 7.5 and 30 min-digestion does not correspond with the 29-kD fragment, as shown in the 1.5-min lanes.
After incubation of gizzard HMM or S-1 with rabbit skeletal muscle F-actin in the absence of ATP, such that all actinbinding sites were occupied, as determined by airfuge sedimentation of IS-1. actin] complexes, little or no inhibition of mAb TGM-1 binding was detected (Fig. 8) . Phosphorylated gizzard HMM was incubated with mAb TGM-I and then assayed for actin-activated Mg2+-ATPase activity. Little or no inhibition was detected under the conditions tested. In contrast, incubation of HMM with mAb TGM-2 resulted in a slight increase in the actin-activated Mg2+-ATPase activity (see Table I ). Phosphorylated gizzard HMM (0.02-0.1 p.M) was incubated at 37°C for 60 rain with monoclonal IgG (0.33/~M) purified by DEAE-cellulo:se chromatography, then assayed for actin-activated Mg2+-ATPase activity as previously described (14) . Pg-x63.Ag8 IgG was used as control. The control HMM ATPase activity was 0.35 p.mol Pi released/min per mg. * Values in heading represent p.M HMM.
Topography of mAb Epitopes
( Fig. 9 B) and [mAb-HMM] complexes (Fig. 9, C and D) were examined, and the topographic localization of bound IgG was determined, mAb TGM-1 mapped specifically to S-l. Two forms of the [TGM-l. S-l] complex were detected (Fig. 9 C) : one antibody attached to the lateral aspect of a single S-I head, or one antibody attached between the two S-1 heads of one HMM molecule (intramolecular cross-linking). Immunoglobulin was present at approximately twofold excess. However, the proportion of nonreactive parental P3-X63.Ag8 IgG and hybrid molecules in the reaction mixture was not determined. Univalent [TGM-I. S-1 ] complexes were essentially symmetric with respect to the long axis of the bound S-l head, and thus were not analyzed for evidence of rotational freedom of the head as was detected using mAbs directed against the amino-terminal 25-kD fragment of skeletal myosin S-I (9). mAb TGM-2, which in peptide binding studies bound S-2 only in the absence of an intact S-2:LMM junction, was mapped specifically to S-2 and was further localized to the carboxy-terminus of S-2 (Fig. 8 D) . The o-helical portion of HMM did not extend beyond bound antibody molecules. Thus, localization ofmAb TGM-I to S-I and TGM-2 to the carboxy-terminus of S-2, based on indirect radioimmunoassay and Western blot techniques, was substantiated by the topography of Individual [mAb.flMM] complexes determined by immunoelectron microscopy. FIGURE "10 Schematic diagram indicating the organization of smooth muscle myosin heavy chain domains. Subunits generated after limited proteolysis with papain (P), yielding S-1 and rod, or with chymotrypsin (CT), yielding HMM and LMM, are labeled above the figure. T, principal sites of tryptic cleavage within S-1 and rod. Secondary sites of cleavage within S-1 by papain (P') or chymotrypsin (CT') are also shown, as well as an amino-terminal S-I site of ATP-dependent chymotryptic digestion (CT.,Tp). For clarity, only one heavy chain is illustrated, and subfragment lengths are not to scale. The topographic specificity of each mAb is indicated below the figure; the 32P-LC20 binding site is labeled for comparison.
D I S C U S S I O N
We have produced and characterized monoclonal antibodies that label epitopes distributed among three distinct, nonoverlapping identified peptide domains of the 200-kD heavy chain of avian smooth muscle myosin. Though turkey gizzard myosin shares similar native structure and domain organization with myosin not only from mammalian smooth muscle but also from striated muscle, the antibodies reported here exhibit specificity for avian smooth muscle myosin alone and do not cross-react with purified myosin from calf aorta, chicken pectoralis, or with avian nonmuscle myosin(s). Localization of the smooth muscle myosin epitopes (Fig. 10) was established by indirect radioimmunoassay employing pudried myosin subunits as well as by Western blot analysis of these subunits or of fragments generated by further proteolysis. By employing low-angle platinum shadowing, we have localized the 50-kD tryptic peptide of S-l, which occupies the mid-portion of the S-1 linear amino acid sequence, to the distal aspect of the myosin head. This finding should be considered in the context of previous reports that mAbs that map to the amino-terminal fragment of S-1 localize to either the upper or lower surface of the head (9) and is consistent with the proposal by Morner et at. (30) regarding the skewed distribution of mass in rabbit skeletal myosin S-1. These observations thus provide the first direct evidence for the topographic organization of the myosin heavy chain within the smooth muscle myosin head and furnish additional evidence that homologous structural organization of domains is conserved even in the presence of significant antigenic diversity among myosins of disparate origin.
